July 23, 2017 9:24 AM ET

Pharmaceuticals

Company Overview of Agensys, Inc.

Key Executives for Agensys, Inc.

NameBoard RelationshipsTitleAge
Leonard M. J. Reyno M.D.No RelationshipsChief Medical Officer and Senior Vice President55
Paul G. Kanan No RelationshipsExecutive Vice President, Chief Financial Officer and Vice President of Operations71

Agensys, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Elizabeth Adkins Czerepak 15 RelationshipsAltimmune, Inc.61
Carl L. Gordon Ph.D., CFA 184 RelationshipsOrbiMed Advisors, L.L.C.52
Roger G. Stoll Ph.D. 27 RelationshipsDelcath Systems, Inc.74
Farah Hyder Champsi 71 RelationshipsAlta Partners LP56
View All Board Members

Agensys, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
428.1K
Bonus
441.7K
Total Short Term Compensation
613.1K
Total Value of Options
8.2M
Compensation as of Fiscal Year
Agensys, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Yichang Hec Changjiang Pharmaceutical Co., Ltd. Receives Resignation Letter by Ms. Xue Lian, Employee Representative Supervisor
July 22, 2017 12:00 AM ET
Reviva Pharmaceuticals Appoints Bradley Thompson to its Board of Directors
July 21, 2017 9:15 PM ET
GlaxoSmithKline PLC Appoints Laurie Glimcher to the Board as Non-Executive Director, Effective September 1, 2017
July 21, 2017 10:00 AM ET
Novartis Pharmaceuticals Corporation Announce Acceptance of US Food and Drug Administration to Review Biologics License Application (Bla) for AMG 334
July 20, 2017 8:38 PM ET
Intersect ENT, Inc. Announces Board Changes, Effective August 1, 2017
July 20, 2017 8:05 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Agensys, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.